Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01789983 · ClinicalTrials.gov registry record

Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy

A clinical trial of Breast Cancer and Lung Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
29
Enrollment target
1
Study location

NCT01789983 is a study of Breast Cancer and Lung Cancer that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 29 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01789983, a study of Breast Cancer and Lung Cancer, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
29 participants
Enrollment target
1
Study location

Study Summary

The study will look at conducting a medium-intense walking program called Walk With Ease with cancer patients age 60 and above who are starting chemotherapy treatment. We will measure how many of these patients complete their participation in this program.

Interventions

  • BEHAVIORAL Walk With Ease Program
  • OTHER Collect Blood, GA and Other Survey Tools

Study Locations (1)

North Carolina

  • University of North Carolina Cancer Hospital - Chapel Hill

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2012-10
Est. Completion 2021-12

What the Registry Record Tells You About NCT01789983

The ClinicalTrials.gov registry entry for NCT01789983 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Walk With Ease Program is the first listed.

NCT01789983 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT01789983 about?

NCT01789983 is a clinical study titled "Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy". The study will look at conducting a medium-intense walking program called Walk With Ease with cancer patients age 60 and above who are starting chemotherapy treatment. We will measure how many of these patients complete their participation in this program.

What is the current status of trial NCT01789983?

This trial is currently completed. The enrollment target is 29 participants. The study started on 2012-10. Estimated completion is 2021-12.

What conditions does trial NCT01789983 study?

This clinical trial studies the following conditions: Breast Cancer, Lung Cancer, Colon Cancer.

What interventions are being tested in trial NCT01789983?

The interventions under investigation include: Walk With Ease Program (BEHAVIORAL), Collect Blood, GA and Other Survey Tools (OTHER).

Who is sponsoring clinical trial NCT01789983?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01789983 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.